Загрузка...
The current status of targeting BAFF/BLyS for autoimmune diseases
It is increasingly recognized that B cells have multiple functions that contribute to the pathogenesis of autoimmunity. Specific targeting of B cells might therefore be an appropriate therapeutic intervention. The tumor necrosis factor-like molecule BAFF (BLyS) is a key B cell survival factor and it...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2004
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC546289/ https://ncbi.nlm.nih.gov/pubmed/15380033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1222 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|